FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter McLaughlin

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Jason R Westin; Vince D Cataldo; Wenli Dong; Michelle A Fanale; Luis E Fayad; Nathan Fowler; Camillo Jimenez; Larry W Kwak; Peter McLaughlin; William A Murphy; Sattva S Neelapu; Barbara Pro; Jorge Romaguera; Felipe Samaniego; Perpetua Sanjorjo; Jatin Shah; Michael A Thompson; Bela Toth; Fredrick B Hagemeister
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
Nicolas Batty; Luis Fayad; Lei Feng; Elham Ghonimi; Larry W Kwak; Peter McLaughlin; Maria Alma Rodriguez; Jorge Enrique Romaguera; Felipe Samaniego; Anas Younes; Fredrick B Hagemeister
The absolute monocyte and lymphocyte prognostic index for patients with diffuse large B-cell lymphoma who receive R-CHOP.
Anas Younes; Amanda Copeland; Silvana de Castro Faria; Kantharaj Ethirajulu; Michelle A Fanale; Fredrick Hagemeister; Stefan Hart; Ramesh Jayaraman; Larry W Kwak; Peter McLaughlin; Sattva S Neelapu; Jorge Romaguera; Jatin Shah; Jeanette Wood; Joy Zhu
Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter McLaughlin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jason R Westin; Vince D Cataldo; Wenli Dong; Michelle A Fanale; Luis E Fayad; Nathan Fowler; Camillo Jimenez; Larry W Kwak; Peter McLaughlin; William A Murphy; Sattva S Neelapu; Barbara Pro; Jorge Romaguera; Felipe Samaniego; Perpetua Sanjorjo; Jatin Shah; Michael A Thompson; Bela Toth; Fredrick B Hagemeister
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
Clinical lymphoma, myeloma & leukemia 2013;13(2):99-105.
2013: Nicolas Batty; Luis Fayad; Lei Feng; Elham Ghonimi; Larry W Kwak; Peter McLaughlin; Maria Alma Rodriguez; Jorge Enrique Romaguera; Felipe Samaniego; Anas Younes; Fredrick B Hagemeister
The absolute monocyte and lymphocyte prognostic index for patients with diffuse large B-cell lymphoma who receive R-CHOP.
Clinical lymphoma, myeloma & leukemia 2013;13(1):15-8.
2012: Anas Younes; Amanda Copeland; Silvana de Castro Faria; Kantharaj Ethirajulu; Michelle A Fanale; Fredrick Hagemeister; Stefan Hart; Ramesh Jayaraman; Larry W Kwak; Peter McLaughlin; Sattva S Neelapu; Jorge Romaguera; Jatin Shah; Jeanette Wood; Joy Zhu
Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(33):4161-7.
2012: Michael Wang; Anas Younes; Ken H Young; Jerome Zeldis; Liang Zhang; Felipe Samaniego; Luhong Sun; Nicolaus Wagner-Bartak; Maria Badillo; Maria Bejarano; Neda Bell; Catriona Byrne; Fernando Cabanillas; Richard Champlin; Wendy Chen; Yiming Chen; Michelle A Fanale; Luis Fayad; Lei Feng; Nathan Fowler; Fredrick Hagemeister; Kimberly Hartig; Larry W Kwak; Peter McLaughlin; Sattva S Neelapu; Kate J Newberry; Jorge Romaguera
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.
The lancet oncology 2012;13(7):716-23.
2012: Nicolas Batty; Amanda Copeland; Bouthaina S Dabaja; Lei Feng; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; Jorge E Romaguera; Felipe Samaniego; Anas Younes
Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study.
Leukemia & lymphoma 2012;53(5):801-6.
2011: Peter McLaughlin
Management options for follicular lymphoma: observe; R-CHOP; B-R; others?
Clinical lymphoma, myeloma & leukemia 2011;11 Suppl 1():S91-5.
2011: Michael Rosenblum; Peter McLaughlin
The pharmacokinetic fate of an immunotoxin: HAMA, HARA, ding, ding, dong.
Leukemia & lymphoma 2011;52(4):550-1.
2010: Jorge Romaguera; Luis Fayad; Peter McLaughlin; Barbara Pro; Alma Rodriguez; Michael Wang; Pamela Weaver; Kimberly Hartig; Larry W Kwak; Tatyana Feldman; Judy Smith; Peggy Ford; Stuart Goldberg; Andrew Pecora; Andre Goy
Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma.
British journal of haematology 2010;151(1):47-53.
2010: Jorge Romaguera; Luis Fayad; Lei Feng; Kimberly Hartig; Pamela Weaver; Maria Alma Rodriguez; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Anas Younes; Felipe Samaniego; Andre Goy; Fernando Cabanillas; Andrew Lamb; Larry Kwak; Michael Wang
Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.
British journal of haematology 2010;150(2):200-8.
2009: Michael Wang; Yasuhiro Oki; Barbara Pro; Jorge Romaguera; Maria Alma Rodriguez; Felipe Samaniego; Peter McLaughlin; Fredrick Hagemeister; Sattva S Neelapu; Amanda Copeland; Barry Samuels; Evelyne M Loyer; Yuan Ji; Anas Younes
Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5213-8.
2009: Peter McLaughlin
Antilymphoma therapy with a Bcl-6 inhibitor.
Current hematologic malignancy reports 2009;4(4):183-4.
2009: Peter McLaughlin; S Sacchi
Interferon: does it still have a role in the 21st century?
Leukemia & lymphoma 2009;50(10):1562-3.
2009: Peter McLaughlin
t(14;18) cells are getting hard to find.
Leukemia & lymphoma 2009;50(7):1063-4.
2009: Bita Esmaeli; Peter McLaughlin; Barbara Pro; Felipe Samaniego; Isis Gayed; Fredrick Hagemeister; Jorge Romaguera; Fernando Cabanillas; Sattva S Neelapu; R Banay; Luis Fayad; M Wayne Saville; Larry W Kwak
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):709-14.
2009: Apostolia-Maria Tsimberidou; Sijin Wen; Peter McLaughlin; Susan O'Brien; William G Wierda; Susan Lerner; Sara Strom; Emil J Freireich; L Jeffrey Medeiros; Hagop M Kantarjian; Michael J Keating
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(6):904-10.
2009: Peter McLaughlin; Jonathan W Friedberg
Seeking wisdom from the Seer.
Leukemia & lymphoma 2009;50(2):145-7.
2008: Michael Wang; Luis Fayad; Fernando Cabanillas; Fredrick Hagemeister; Peter McLaughlin; Maria A Rodriguez; Larry W Kwak; Yuhong Zhou; Andrew Lamb; Jorge Romaguera
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Cancer 2008;113(10):2734-41.
2008: Issa F Khouri; Peter McLaughlin; Rima M Saliba; Chitra Hosing; Martin Korbling; Ming S Lee; L Jeffrey Medeiros; Luis Fayad; Felipe Samaniego; Amin Alousi; Paolo Anderlini; Daniel Couriel; Marcos De Lima; Sergio Giralt; Sattva S Neelapu; Naoto T Ueno; Barry I Samuels; Fredrick Hagemeister; Larry W Kwak; Richard E Champlin
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
Blood 2008;111(12):5530-6.
2008: Justin J Leitenberger; Cindy N Berthelot; Kristel D Polder; Barbara Pro; Peter McLaughlin; Dan Jones; Madeleine Duvic
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Journal of the American Academy of Dermatology 2008;58(3):480-4.
2008: M J Overman; L Feng; Barbara Pro; Peter McLaughlin; Mark Hess; Felipe Samaniego; Anas Younes; Jorge Romaguera; Fredrick B Hagemeister; Larry W Kwak; Fernando Cabanillas; Maria A Rodriguez; Luis Fayad
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):553-9.
2008: Yasuhiro Oki; Barbara Pro; Luis Fayad; Jorge Romaguera; Felipe Samaniego; Fredrick Hagemeister; Sattva S Neelapu; Peter McLaughlin; Andre Goy; Anas Younes
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.
Cancer 2008;112(4):831-6.
2007: Elham Hatef; Dianna Roberts; Peter McLaughlin; Barbara Pro; Bita Esmaeli
Prevalence and nature of systemic involvement and stage at initial examination in patients with orbital and ocular adnexal lymphoma.
Archives of ophthalmology 2007;125(12):1663-7.
2007: Apostolia-Maria Tsimberidou; Sijin Wen; Susan O'Brien; Peter McLaughlin; William G Wierda; Alessandra Ferrajoli; Stefan Faderl; John Manning; Susan Lerner; Chinh V Mai; Alma M Rodriguez; Mark Hess; Kim-Anh Do; Emil J Freireich; Hagop M Kantarjian; L Jeffrey Medeiros; Michael J Keating
Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4648-56.
2007: Nam H Dang; Luis Fayad; Peter McLaughlin; Jorge E Romaguara; Fredrick Hagemeister; Andre Goy; Sattva S Neelapu; Felipe Samaniego; Pamela L Walker; Michael Wang; Maria A Rodriguez; Ann T Tong; Barbara Pro
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma.
British journal of haematology 2007;138(4):502-5.
2007: Isis Gayed; M Farahnaz Eskandari; Peter McLaughlin; Barbara Pro; Roxana Diba; Bita Esmaeli
Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2007;38(4):319-25.
2007: Barbara Pro; Peter McLaughlin
Angioimmunoblastic T-cell lymphoma: still a dismal prognosis with current treatment approaches.
Leukemia & lymphoma 2007;48(4):645-6.
2007: Dan Iancu; Suyang Hao; Pei Lin; S Keith Anderson; Jeffrey L Jorgensen; Peter McLaughlin; L Jeffrey Medeiros
Follicular lymphoma in staging bone marrow specimens: correlation of histologic findings with the results of flow cytometry immunophenotypic analysis.
Archives of pathology & laboratory medicine 2007;131(2):282-7.
2007: Nam H Dang; Barbara Pro; Fredrick B Hagemeister; Felipe Samaniego; Dan Jones; Barry Samuels; Maria A Rodriguez; Andre Goy; Jorge Romaguera; Peter McLaughlin; Ann T Tong; Francesco Turturro; Pamela L Walker; Luis Fayad
Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma.
British journal of haematology 2007;136(3):439-47.
2007: Yasuhiro Oki; Peter McLaughlin; Luis Fayad; Barbara Pro; Paul F Mansfield; Gary L Clayman; L Jeffrey Medeiros; Larry W Kwak; Pramod K Srivastava; Anas Younes
Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.
Cancer 2007;109(1):77-83.
2006: Amar Safdar; Maria A Rodriguez; Luis Fayad; Gilhen H Rodriguez; Barbara Pro; Michael Wang; Jorge Romaguera; Andre Goy; Fredrick B Hagemeister; Peter McLaughlin; Gerald P Bodey; Larry W Kwak; Issam I Raad; Robert B Couch
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.
The Journal of infectious diseases 2006;194(10):1394-7.
2006: Barbara Pro; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; Maria A Rodriguez; Fernando Cabanillas; Lili Paz Tiongson; Anas Younes
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2006;47(9):1818-21.
2006: Qi Liu; Luis Fayad; Fernando Cabanillas; Fredrick B Hagemeister; Gregory D Ayers; Mark Hess; Jorge Romaguera; Maria A Rodriguez; Apostolia-Maria Tsimberidou; Srdan Verstovsek; Anas Younes; Barbara Pro; Ming-Sheng Lee; Ana Ayala; Peter McLaughlin
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1582-9.
2006: Barbara Pro; Luis Fayad; Peter McLaughlin; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Andre Goy; Evelyne M Loyer; Anas Younes
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma.
Leukemia & lymphoma 2006;47(3):481-5.
2006: Peter McLaughlin
The indolent B-cell lymphomas.
Cancer treatment and research 2006;131():89-120.
2006: Peter McLaughlin; Vrinda Narayana; Charlie Pan; Sally Berri; Sara Troyer; JOSEPH HERMAN; Vicki Evans; Peter L Roberson
Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds.
International journal of radiation oncology, biology, physics 2006;64(1):144-50.
2005: Jorge Romaguera; Luis Fayad; Maria A Rodriguez; Kristine Broglio; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Anas Younes; Felipe Samaniego; Andre Goy; Andreas H Sarris; Nam H Dang; Michael Wang; Virginia Beasley; L Jeffrey Medeiros; Ruth Katz; Harish K Gagneja; Barry Samuels; Terry L Smith; Fernando Cabanillas
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7013-23.
2005: Chul Ha; Fernando Cabanillas; Ming S Lee; Susan L Tucker; Peter McLaughlin; Maria A Rodriguez; Anas Younes; Jorge Romaguera; Ofelia M Mesina; James D Cox
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.
International journal of radiation oncology, biology, physics 2005;63(1):188-93.
2005: Yasuhiro Oki; Peter McLaughlin; Barbara Pro; Fredrick B Hagemeister; Archie Bleyer; Evelyne M Loyer; Anas Younes
Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma.
Cancer 2005;104(4):781-7.
2005: Apostolia-Maria Tsimberidou; Anas Younes; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Lei Feng; Ana Ayala; Terry L Smith; Fernando Cabanillas; Peter McLaughlin
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
Cancer 2005;104(2):345-53.
2005: Peter McLaughlin; Elihu Estey; Armand B. Glassman; Jorge Romaguera; Felipe Samaniego; Ana Ayala; Kimberly Hayes; Anne Marie Maddox; H Alejandro Preti; Fredrick B Hagemeister
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha.
Blood 2005;105(12):4573-5.
2005: Issa F Khouri; Rima M Saliba; Chitra Hosing; Grace-Julia Okoroji; Sandra Acholonu; Paolo Anderlini; Daniel Couriel; Marcos De Lima; Michele L Donato; Luis Fayad; Sergio Giralt; Roy Jones; Martin Korbling; Farzaneh Maadani; John T Manning; Barbara Pro; Elizabeth J Shpall; Anas Younes; Peter McLaughlin; Richard E Champlin
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2240-7.
2005: Andre Goy; Anas Younes; Peter McLaughlin; Barbara Pro; Jorge Romaguera; Fredrick Hagemeister; Luis Fayad; Nam H Dang; Felipe Samaniego; Michael Wang; Kristine Broglio; Barry Samuels; Frederic Gilles; Andreas H Sarris; Susan Hart; Elizabeth Trehu; David P Schenkein; Fernando Cabanillas; Alma M Rodriguez
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):667-75.
2004: Nam H Dang; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Jorge Romaguera; Dan Jones; Barry Samuels; Felipe Samaniego; Anas Younes; Michael Wang; Andre Goy; Maria A Rodriguez; Pamela L Walker; Yolanda Arredondo; Ann T Tong; Luis Fayad
Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4095-102.
2004: Maricer Escalon; Richard E Champlin; Rima M Saliba; Sandra Acholonu; Chitra Hosing; Luis Fayad; Sergio Giralt; Naoto T Ueno; Farzaneh Maadani; Barbara Pro; Michele Donato; Peter McLaughlin; Issa F Khouri
Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2419-23.
2004: Barbara Pro; Anas Younes; Maher Albitar; Nam H Dang; Felipe Samaniego; Jorge Romaguera; Peter McLaughlin; Fredrick B Hagemeister; Maria A Rodriguez; Marilyn Clemons; Fernando Cabanillas
Thalidomide for patients with recurrent lymphoma.
Cancer 2004;100(6):1186-9.
2004: Chul Ha; Ming-Sheng Lee; Peter McLaughlin; Susan L Tucker; Richard B Wilder; James D Cox; Fernando Cabanillas
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).
Cancer journal (Sudbury, Mass.) 2004;10(1):49-53.
2003: Issa F Khouri; Ming-S Lee; Rima M Saliba; Gu Jun; Luis Fayad; Anas Younes; Barbara Pro; Sandra Acholonu; Peter McLaughlin; Ruth Katz; Richard E Champlin
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23):4407-12.
2003: Chul Ha; Joseph S Kong; Peter McLaughlin; Susan L Tucker; Luis Fayad; Mark A Hess; Richard B Wilder; Fernando Cabanillas; James D Cox
Stage III follicular lymphoma: long-term follow-up and patterns of failure.
International journal of radiation oncology, biology, physics 2003;57(3):748-54.
2003: Chul Ha; Joseph S Kong; Susan L Tucker; Peter McLaughlin; Richard B Wilder; Mark A Hess; Fernando Cabanillas; James D Cox
Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.
International journal of radiation oncology, biology, physics 2003;57(2):316-20.
2003: Bouthaina S Dabaja; Peter McLaughlin; Chul Ha; Barbara Pro; Christina A Meyers; Lee F Seabrooke; Richard B Wilder; Athanassios P Kyritsis; H Alejandro Preti; W K Alfred Yung; Victor Levin; Fernando Cabanillas; James D Cox
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Cancer 2003;98(5):1021-8.
2003: Nam H Dang; Fredrick B Hagemeister; Madeleine Duvic; Jorge Romaguera; Anas Younes; Dan Jones; Barry Samuels; Luis Fayad; Barbara Pro; Felipe Samaniego; Andreas H Sarris; Andre Goy; Peter McLaughlin; Ann T Tong; Pamela L Walker; Lili Paz Tiongson; Terry L Smith; Yang O Huh; Chikao Morimoto; Maria A Rodriguez
Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.
Oncology reports 2003;10(5):1513-8.
2003: Anas Younes; Jorge Romaguera; Fredrick Hagemeister; Peter McLaughlin; Maria A Rodriguez; Paolo Fiumara; Andre Goy; Sima Jeha; John T Manning; Dan Jones; Lynne V Abruzzo; L Jeffrey Medeiros
A pilot study of rituximab in patients with recurrent, classic Hodgkin disease.
Cancer 2003;98(2):310-4.
2003: Robert Takamiya; Vivian Weinberg; C Dale Young; Howard Sandler; Peter McLaughlin; Mack Roach
A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancer.
International journal of radiation oncology, biology, physics 2003;56(4):1073-8.
2003: Bouthaina S Dabaja; Chul Ha; Richard B Wilder; Barbara Pro; Peter McLaughlin; Fernando Cabanillas; James D Cox
Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma.
Cancer journal (Sudbury, Mass.) 2003;9(4):321-4.
2003: Christina Tsien; Kent Andrew Griffith; Howard M Sandler; Peter McLaughlin; Martin G Sanda; James E Montie; Shilpa Reddy; James A Hayman
Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy.
Urology 2003;62(1):93-8.
2003: John F Seymour; Barbara Pro; Lillian M Fuller; John T Manning; Fredrick B Hagemeister; Jorge Romaguera; Maria A Rodriguez; Chul Ha; Terry L Smith; Ana Ayala; Mark Hess; James D Cox; Fernando Cabanillas; Peter McLaughlin
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2115-22.
2003: Chitra Hosing; Rima M Saliba; Peter McLaughlin; Borje Andersson; Maria A Rodriguez; Luis Fayad; Fernando Cabanillas; Richard E Champlin; Issa F Khouri
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(5):737-44.
2003: Hagop M Kantarjian; Varsha Gandhi; Peter Kozuch; Stefan Faderl; Francis Giles; Jorge Cortes; Susan O'Brien; Nuhad Ibrahim; Fadlo R Khuri; Min Du; Mary Beth Rios; Sima Jeha; Peter McLaughlin; William Plunkett; Michael Keating
Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1167-73.
2003: Jorge Romaguera; L Jeffrey Medeiros; Fredrick B Hagemeister; Luis Fayad; Maria A Rodriguez; Barbara Pro; Anas Younes; Peter McLaughlin; Andre Goy; Andreas H Sarris; Nam H Dang; Felipe Samaniego; H M Brown; Harish K Gagneja; Fernando Cabanillas
Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.
Cancer 2003;97(3):586-91.
2002: Apostolia-Maria Tsimberidou; Peter McLaughlin; Anas Younes; Maria A Rodriguez; Fredrick B Hagemeister; Andreas H Sarris; Jorge Romaguera; Mark Hess; Terry L Smith; Ying Yang; Ana Ayala; Alejandro Preti; Ming-Sheng Lee; Fernando Cabanillas
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Blood 2002;100(13):4351-7.
2002: Bita Esmaeli; James L Murray; M Amir Ahmadi; Aresu Naderi; Sanjay Singh; Jorge Romaguera; Christine White; Peter McLaughlin
Immunotherapy for low-grade non-hodgkin secondary lymphoma of the orbit.
Archives of ophthalmology 2002;120(9):1225-7.
2002: Apostolia-Maria Tsimberidou; Yunfang Jiang; Richard J Ford; Benjamin Lichtiger; L Jeffrey Medeiros; Peter McLaughlin; Fernando Cabanillas; Andreas H Sarris
Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma.
Leukemia & lymphoma 2002;43(8):1589-98.
2002: Andreas H Sarris; Alexandria Phan; Andre Goy; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Barbara Pro; L Jeffrey Medeiros; Barry Samuels; Ofelia M Mesina; Archie Bleyer; Fernando Cabanillas
Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial.
Oncology (Williston Park, N.Y.) 2002;16(8 Suppl 7):27-31.
2002: Carlo Visco; L Jeffrey Medeiros; Dan Jones; T Smith; Maria A Rodriguez; Peter McLaughlin; Jorge Romaguera; Fernando Cabanillas; Andreas H Sarris
Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(8):1290-9.
2002: Andreas H Sarris; Alexandria Phan; Madeleine Duvic; Jorge Romaguera; Peter McLaughlin; Ofelia M Mesina; K King; L Jeffrey Medeiros; George Z Rassidakis; Barry Samuels; Fernando Cabanillas
Trimetrexate in relapsed T-cell lymphoma with skin involvement.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(12):2876-80.
2002: Hesham M Amin; Peter McLaughlin; Cynthia J Rutherford; Lynne V Abruzzo; Dan Jones
Cutaneous and systemic plasmacytosis in a patient of Asian descent living in the United States.
The American Journal of dermatopathology 2002;24(3):241-5.
2002: George Z Rassidakis; L Jeffrey Medeiros; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Ofelia M Mesina; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1278-87.
2002: Andreas H Sarris; Yunfang Jiang; Apostolia-Maria Tsimberidou; Athanasios Thomaides; George Z Rassidakis; Richard J Ford; L Jeffrey Medeiros; Fernando Cabanillas; Peter McLaughlin
Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone.
Seminars in oncology 2002;29(1 Suppl 2):48-55.
2002: Peter McLaughlin
Progress and promise in the treatment of indolent lymphomas.
The oncologist 2002;7(3):217-25.
2001: Issa F Khouri; Rima M Saliba; Sergio Giralt; Ming-Sheng Lee; Grace-Julia Okoroji; Fredrick B Hagemeister; Martin Korbling; Anas Younes; Cindy Ippoliti; James L Gajewski; Peter McLaughlin; Paolo Anderlini; Michele L Donato; Fernando Cabanillas; Richard E Champlin
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
Blood 2001;98(13):3595-9.
2001: Richard B Wilder; Dan Jones; Susan L Tucker; Lillian M Fuller; Chul Ha; Peter McLaughlin; Mark A Hess; Fernando Cabanillas; James D Cox
Long-term results with radiotherapy for Stage I-II follicular lymphomas.
International journal of radiation oncology, biology, physics 2001;51(5):1219-27.
2001: Chul Ha; Susan L Tucker; Angel I Blanco; Richard B Wilder; Peter McLaughlin; Fernando Cabanillas; James D Cox
Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma.
Cancer 2001;92(5):1074-9.
2001: Anas Younes; H Alejandro Preti; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; Maria A Rodriguez; Barry Samuels; J Lynn Palmer; Fernando Cabanillas
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(7):923-7.
2001: Andreas H Sarris; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Barbara Pro; Anas Younes; Ofelia M Mesina; Fernando Cabanillas; L Jeffrey Medeiros; Barry Samuels
Irinotecan in relapsed or refractory non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 2001;15(7 Suppl 8):53-6.
2001: Carlo Visco; L Jeffrey Medeiros; Ofelia M Mesina; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; Fernando Cabanillas; Andreas H Sarris
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
Clinical lymphoma 2001;2(1):40-6.
2001: Apostolia-Maria Tsimberidou; Andreas H Sarris; L Jeffrey Medeiros; Ofelia M Mesina; Maria A Rodriguez; Fredrick B Hagemeister; Jorge Romaguera; Barbara Pro; Peter McLaughlin; N Dang; Fernando Cabanillas
Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
Leukemia & lymphoma 2001;41(5-6):535-44.
2001: Chitra Hosing; R S Freedman; Peter McLaughlin; Anais Malpica; Bruno D Fornage; AP Kudelka
Diffuse large B-cell non-Hodgkin's lymphoma presenting as a vaginal mass in a patient with a history of intestinal mucosa-associated lymphoid tissue (MALT) lymphoma.
American journal of clinical oncology 2001;24(2):204-8.
2001: Chul Ha; Susan L Tucker; Ming-Sheng Lee; Peter McLaughlin; Fernando Cabanillas; James D Cox
The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
International journal of radiation oncology, biology, physics 2001;49(3):727-32.
2001: Andreas H Sarris; Ira Braunschweig; L Jeffrey Medeiros; Madeleine Duvic; Chul Ha; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; J Cox; Fernando Cabanillas
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):398-405.
2000: Anas Younes; M Cristofanilli; Peter McLaughlin; Fredrick B Hagemeister; Donna Weber; Ofelia M Mesina; Fernando Cabanillas
Experience with 9-cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphoma.
Leukemia & lymphoma 2000;40(1-2):79-85.
2000: Peter McLaughlin; Fredrick B Hagemeister; Maria A Rodriguez; Andreas H Sarris; O Pate; Anas Younes; Ming-Sheng Lee; Nam H Dang; Jorge Romaguera; Alejandro Preti; N McAda; Fernando Cabanillas
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma.
Seminars in oncology 2000;27(6 Suppl 12):37-41.
2000: Jose Rodriguez; Peter McLaughlin; Luis Fayad; M Santiago; Mark Hess; Maria A Rodriguez; Jorge Romaguera; Fredrick Hagemeister; Andrew Lamb; Fernando Cabanillas
Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(12):1551-6.
2000: Andreas H Sarris; A Psyrri; Fredrick Hagemeister; Jorge Romaguera; Peter McLaughlin; Maria A Rodriguez; CR Bachier; Anas Younes; Ofelia M Mesina; M Oholendt; L Jeffrey Medeiros; Barry Samuels; Laurel M Adams; Fernando Cabanillas
Infusional vinorelbine in relapsed or refractory lymphomas.
Leukemia & lymphoma 2000;39(3-4):291-9.
2000: Paolo Anderlini; Sergio Giralt; Borje Andersson; Naoto T Ueno; Issa Khouri; Sandra Acholonu; Agueda Cohen; Martin Körbling; J Manning; Jorge Romaguera; Andreas H Sarris; Fredrick Hagemeister; Peter McLaughlin; Fernando Cabanillas; Richard E Champlin
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.
Bone marrow transplantation 2000;26(6):615-20.
2000: Jorge Romaguera; Issa F Khouri; Hagop M Kantarjian; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Andreas H Sarris; Anas Younes; Jose Rodriguez; Fernando Cabanillas
Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patients.
Leukemia & lymphoma 2000;39(1-2):77-85.
2000: Zhongxing Liao; Chul Ha; Peter McLaughlin; JT Manning; Mark Hess; Fernando Cabanillas; James D Cox
Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression.
International journal of radiation oncology, biology, physics 2000;48(2):399-403.
2000: A López-Guillermo; Fernando Cabanillas; Peter McLaughlin; T Smith; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; WC Pugh; Ming-Sheng Lee
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():137-40.
2000: Andreas H Sarris; Fredrick Hagemeister; Jorge Romaguera; Maria A Rodriguez; Peter McLaughlin; Apostolia-Maria Tsimberidou; L Jeffrey Medeiros; Barry Samuels; O Pate; M Oholendt; Andrew Lamb; C Burge; Fernando Cabanillas
Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):69-72.
1999: Michele L Donato; Richard E Champlin; Koen van Besien; Martin Korbling; Fernando Cabanillas; Paolo Anderlini; J G Gajewski; Jo Lauppe; April Durett; Borje Andersson; Sergio Giralt; Issa Khouri; Fredrick Hagemeister; Jorge Romaguera; Andreas H Sarris; Peter McLaughlin; Anas Younes; Cindy Ippoliti; D A Blamble; Jeane Hester; Adrian Gee; Maria A Rodriguez
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;35(3-4):317-24.
1999: Peter McLaughlin; Fredrick B Hagemeister; Antonio J Grillo-López
Rituximab in indolent lymphoma: the single-agent pivotal trial.
Seminars in oncology 1999;26(5 Suppl 14):79-87.
1999: James C Yao; N Thomakos; Peter McLaughlin; Thomas Buchholz; AP Kudelka
Tamoxifen-induced thrombocytopenia.
American journal of clinical oncology 1999;22(5):529-32.
1999: Peter McLaughlin
Treatment of follicular and other indolent lymphomas.
Current opinion in oncology 1999;11(5):333-8.
1999: Jose Rodriguez; Maria A Rodriguez; Luis Fayad; Peter McLaughlin; F Swan; Andreas H Sarris; Jorge Romaguera; Borje Andersson; Fernando Cabanillas; Fredrick B Hagemeister
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease.
Blood 1999;93(11):3632-6.
1999: A López-Guillermo; Fernando Cabanillas; Timothy J McDonnell; Peter McLaughlin; T Smith; WC Pugh; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; Ming-Sheng Lee
Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
Blood 1999;93(9):3081-7.
1999: Andreas H Sarris; Kay-Oliver Kliche; P Pethambaram; Alejandro Preti; S Tucker; CM Jackow; O Messina; WC Pugh; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Herbert A Fritsche; T Witzig; Madeleine Duvic; Michael Andreeff; Fernando Cabanillas
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):433-40.
1999: Jose Rodriguez; Peter McLaughlin; Fredrick B Hagemeister; Luis Fayad; Maria A Rodriguez; M Santiago; Mark Hess; Jorge Romaguera; Fernando Cabanillas
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
Blood 1999;93(7):2202-7.
1999: Peter McLaughlin
Inroads in the therapy of indolent lymphomas: exploiting biological insights.
Cancer investigation 1999;17(1):73-86.
1999: Jorge Romaguera; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; J Rodriguez; A Preti; Anas Younes; Andreas H Sarris; Fernando Cabanillas
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination.
Investigational new drugs 1999;17(2):187-92.
1998: Jorge Romaguera; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; CR Bachier; H Alejandro Preti; Andreas H Sarris; Donna Weber; Anas Younes; Fernando Cabanillas
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.
Leukemia & lymphoma 1998;32(1-2):97-106.
1998: Peter McLaughlin; Christine White; A J Grillo-López; D G Maloney
Clinical status and optimal use of rituximab for B-cell lymphomas.
Oncology (Williston Park, N.Y.) 1998;12(12):1763-9; discussion 1769-70, 1775-7,.
1998: Anas Younes; Jorge Romaguera; Ofelia M Mesina; Fredrick Hagemeister; Andreas H Sarris; Maria A Rodriguez; Peter McLaughlin; H Alejandro Preti; CR Bachier; Fernando Cabanillas
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma.
British journal of haematology 1998;103(3):678-83.
1998: Luis Fayad; Fernando Cabanillas; Moshe Talpaz; Peter McLaughlin; Razelle Kurzrock
High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma.
Leukemia & lymphoma 1998;30(5-6):563-71.
1998: Peter McLaughlin; Antonio J Grillo-López; B K Link; Ronald Levy; Myron S Czuczman; M E Williams; M R Heyman; I Bence-Bruckler; Christine White; Fernando Cabanillas; V Jain; A D Ho; J Lister; K Wey; D Shen; BK Dallaire
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2825-33.
1998: Fernando Cabanillas; J Rodriguez-Diaz Pavón; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; K Dong; T Moon
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(5):511-8.
1998: A López-Guillermo; Fernando Cabanillas; Peter McLaughlin; T Smith; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; WC Pugh; Ming-Sheng Lee
The clinical significance of molecular response in indolent follicular lymphomas.
Blood 1998;91(8):2955-60.
1998: Koen van Besien; Chul Ha; S Murphy; Peter McLaughlin; A Rodriguez; K Amin; A Forman; Jorge Romaguera; Fredrick Hagemeister; Anas Younes; CR Bachier; Andreas H Sarris; K S Sobocinski; James D Cox; Fernando Cabanillas
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
Blood 1998;91(4):1178-84.
1998: Lillian M Fuller; Nadeem Q Mirza; J Lynn Palmer; B R Davis; Chul Ha; Maria A Rodriguez; Fredrick B Hagemeister; Fernando Cabanillas; Peter McLaughlin; J J Butler; LB North; R G Martin
Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage II.
International journal of radiation oncology, biology, physics 1998;40(2):377-86.
1998: Jorge Romaguera; J Rodríguez Díaz-Pavon; L Carías; Fredrick B Hagemeister; Peter McLaughlin; M A Rodríguez; Andreas H Sarris; Anas Younes; Alejandro Preti; CR Bachier; E Llerena; Fernando Cabanillas
Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patients.
Leukemia & lymphoma 1998;28(3-4):295-306.
1997: Michael J Keating; Peter McLaughlin; Fernando Cabanillas
Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND).
European journal of cancer care 1997;6(4 Suppl):21-6.
1997: Marvin L Meistrich; Gene Wilson; K Mathur; Lillian M Fuller; Maria A Rodriguez; Peter McLaughlin; Jorge Romaguera; Fernando Cabanillas; Chul Ha; Larry I Lipshultz; Fredrick B Hagemeister
Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(12):3488-95.
1997: Anas Younes; Maria A Rodriguez; Peter McLaughlin; LB North; Andreas H Sarris; O Pate; Fredrick B Hagemeister; Jorge Romaguera; Alejandro Preti; CR Bachier; Fernando Cabanillas
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 1997;26(1-2):77-82.
1997: Andreas H Sarris; V Papadimitrakopoulou; Meletios A Dimopoulos; T Smith; WC Pugh; Chul Ha; Peter McLaughlin; David L Callender; J Cox; Fernando Cabanillas
Primary parotid lymphoma: the effect of International Prognostic Index on outcome.
Leukemia & lymphoma 1997;26(1-2):49-56.
1997: Chul Ha; Fernando Cabanillas; Ming-Sheng Lee; PC Besa; Peter McLaughlin; James D Cox
Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):215-9.
1997: Anas Younes; JP Ayoub; Andreas H Sarris; Fredrick Hagemeister; LB North; O Pate; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; R Kurzrock; Alejandro Preti; CR Bachier; T Smith; Fernando Cabanillas
Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial.
British journal of haematology 1997;96(2):328-32.
1997: Anas Younes; JP Ayoub; Andreas H Sarris; LB North; O Pate; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Fredrick Hagemeister; CR Bachier; Alejandro Preti; Fernando Cabanillas
Paclitaxel (Taxol) for the treatment of lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():129-31.
1996: Michael J Keating; Susan O'Brien; Peter McLaughlin; Meletios A Dimopoulos; Varsha Gandhi; William Plunkett; Susan Lerner; Andrew Lamb; Elihu Estey
Clinical experience with fludarabine in hemato-oncology.
Hematology and cell therapy 1996;38 Suppl 2():S83-91.
1996: Peter McLaughlin; F B Hagemeister; Jorge Romaguera; Andreas H Sarris; O Pate; Anas Younes; F Swan; Michael Keating; Fernando Cabanillas
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1262-8.
1996: Anas Younes; Andreas H Sarris; U Consoli; A Rodriguez; Peter McLaughlin; Y Huh; S Starry; Fernando Cabanillas; Michael Andreeff
A pilot study of high-dose interleukin-3 treatment of relapsed follicular small cleaved-cell lymphoma: hematologic, immunologic, and clinical results.
Blood 1996;87(5):1698-703.
1996: J F Seymour; Peter McLaughlin; Lillian M Fuller; F B Hagemeister; M Hess; F Swan; Jorge Romaguera; Maria A Rodriguez; PC Besa; J Cox; Fernando Cabanillas
High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(2):157-63.
1996: Anas Younes; JP Ayoub; F B Hagemeister; Peter McLaughlin; Andreas H Sarris; Maria A Rodriguez; F Swan; Jorge Romaguera; J Martin; Fernando Cabanillas
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):543-8.
1996: Andreas H Sarris; Anas Younes; Peter McLaughlin; D Moore; F Hagemeister; F Swan; Maria A Rodriguez; Jorge Romaguera; LB North; P Mansfield; D Callendar; O Mesina; Fernando Cabanillas
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):233-9.
1995: Meir Wetzler; Razelle Kurzrock; AM Goodacre; Peter McLaughlin; S Ku; Moshe Talpaz
Transformation of chronic lymphocytic leukemia to lymphoma of true histiocytic type.
Cancer 1995;76(4):609-17.
1995: Maria A Rodriguez; F C Cabanillas; F B Hagemeister; Peter McLaughlin; Jorge Romaguera; F Swan; W Velasquez
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(6):609-11.
1995: Maria A Rodriguez; F C Cabanillas; W Velasquez; F B Hagemeister; Peter McLaughlin; F Swan; Jorge Romaguera
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1734-41.
1995: S Suki; F Swan; S Tucker; Herbert A Fritsche; J R Redman; Maria A Rodriguez; Peter McLaughlin; Jorge Romaguera; F B Hagemeister; W S Velasquez
Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase.
Leukemia & lymphoma 1995;18(1-2):87-92.
1995: Andreas H Sarris; Alejandro Majlis; Meletios A Dimopoulos; Anas Younes; F Swann; Maria A Rodriguez; Peter McLaughlin; Fernando Cabanillas
Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma.
Leukemia & lymphoma 1995;17(5-6):473-7.
1995: Anas Younes; Andreas H Sarris; A Melnyk; Jorge Romaguera; Peter McLaughlin; F Swan; Maria A Rodriguez; F Hagemeister; D Moore; LB North
Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):583-7.
1995: D F Moore; F Swan; J Yau; Maria A Rodriguez; Peter McLaughlin; Andreas H Sarris; Jorge Romaguera; Anas Younes; F B Hagemeister; Fernando Cabanillas
Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: a phase II study.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1995;7(5):300-3.
1995: Lillian M Fuller; M J Krasin; W S Velasquez; Pamela K Allen; Peter McLaughlin; Maria A Rodriguez; F B Hagemeister; F Swan; Fernando Cabanillas; J L Palmer
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation.
International journal of radiation oncology, biology, physics 1995;31(1):3-11.
1994: Jose Rodriguez; WC Pugh; Jorge Romaguera; Rajyalakshmi Luthra; F B Hagemeister; Peter McLaughlin; Maria A Rodriguez; F Swan; Fernando Cabanillas
Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):847-9.
1994: W S Velasquez; Peter McLaughlin; S Tucker; F B Hagemeister; F Swan; Maria A Rodriguez; Jorge Romaguera; Edward B Rubenstein; Fernando Cabanillas
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1169-76.
1994: W S Velasquez; Peter McLaughlin; Lillian M Fuller; Pamela K Allen; Susan L Tucker; F Swan; Maria A Rodriguez; F B Hagemeister; Fernando Cabanillas
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Cancer 1994;73(9):2408-16.
1994: F B Hagemeister; R Purugganan; L Fuller; Peter McLaughlin; F Swan; Jorge Romaguera; M Rodriguez; Fernando Cabanillas
Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Seminars in hematology 1994;31(2 Suppl 3):36-43.
1994: Peter McLaughlin; F B Hagemeister; F Swan; Fernando Cabanillas; O Pate; Jorge Romaguera; Maria A Rodriguez; J R Redman; Michael Keating
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):575-9.
1994: Michael J Keating; Peter McLaughlin; William Plunkett; LE Robertson; Susan O'Brien; Varsha Gandhi; V Gregoire; L Yang; Fernando Cabanillas
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():79-83.
1994: F B Hagemeister; R Purugganan; D A Podoloff; M Hess; Maria A Rodriguez; Peter McLaughlin; F Swan; Jorge Romaguera; Fernando Cabanillas
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():59-63.
1994: F B Hagemeister; R Khetan; P Allen; Peter McLaughlin; Maria A Rodriguez; F Swan; Jorge Romaguera; Fernando Cabanillas
Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():41-6.
1994: Jorge Romaguera; Maria A Rodriguez; F B Hagemeister; Peter McLaughlin; F Swan; D F Moore; Andreas H Sarris; Anas Younes; D Hill; Fernando Cabanillas
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
Investigational new drugs 1994;12(3):217-22.
1994: Michael J Keating; Susan O'Brien; LE Robertson; Andrew Lamb; Meletios A Dimopoulos; Peter McLaughlin; Fernando Cabanillas; V Gregoire; Y Y Li; Varsha Gandhi
The expanding role of fludarabine in hematologic malignancies.
Leukemia & lymphoma 1994;14 Suppl 2():11-6.
1994: Alejandro Preti; F B Hagemeister; Peter McLaughlin; F Swan; A Rodriguez; PC Besa; James D Cox; Pamela K Allen; Fernando Cabanillas
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():97-100.
1994: Peter McLaughlin; F B Hagemeister; F Swan; Fernando Cabanillas; Jorge Romaguera; Maria A Rodriguez; M S Lee; O Pate; Andreas H Sarris; Anas Younes
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():73-7.
1993: LE Robertson; WC Pugh; Susan O'Brien; Andrew Lamb; Cheryl Hirsch-Ginsberg; A Cork; Peter McLaughlin; Fernando Cabanillas; Michael J Keating
Richter's syndrome: a report on 39 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1985-9.
1993: Michael J Keating; Susan O'Brien; LE Robertson; Andrew Lamb; Meletios A Dimopoulos; Peter McLaughlin; Fernando Cabanillas; V Gregoire; Li-Ying Yang; Varsha Gandhi
New initiatives with fludarabine monophosphate in hematologic malignancies.
Seminars in oncology 1993;20(5 Suppl 7):13-20.
1993: Kapil Dhingra; Madeleine Duvic; S Hymes; Peter McLaughlin; J Rothberg; Jordan U Gutterman
A phase-I clinical study of low-dose oral interferon-alpha.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(1):51-5.
1993: LE Robertson; R Hall; Michael J Keating; Elihu Estey; Hagop M Kantarjian; Peter McLaughlin; F B Hagemeister; William Plunkett
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysis.
Leukemia & lymphoma 1993;10(1-2):43-8.
1993: Peter McLaughlin; Fernando Cabanillas; F B Hagemeister; F Swan; Jorge Romaguera; S Taylor; Maria A Rodriguez; W S Velasquez; J R Redman; Jordan U Gutterman
CHOP-Bleo plus interferon for stage IV low-grade lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(3):205-11.
1993: Maria A Rodriguez; Lillian M Fuller; Stuart O Zimmerman; Pamela K Allen; B W Brown; M F Munsell; F B Hagemeister; Peter McLaughlin; W S Velasquez; F Swan
Hodgkin's disease: study of treatment intensities and incidences of second malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(2):125-31.
1993: R M Pryzant; Marvin L Meistrich; G Wilson; B Brown; Peter McLaughlin
Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):239-47.
1993: Peter McLaughlin
The role of interferon in the therapy of low grade lymphoma.
Leukemia & lymphoma 1993;10 Suppl():17-20.
1992: R Vassilopoulou-Sellin; Peter McLaughlin; R C Hickey
Case report: diagnosis of thyroid cancer by bone marrow biopsy in a patient with lymphoma and goiter.
The American journal of the medical sciences 1992;304(6):360-2.
1992: F B Hagemeister; L Fuller; Peter McLaughlin; M Rodriguez; Jorge Romaguera; F Swan; Fernando Cabanillas
NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():87-90.
1992: J R Redman; Fernando Cabanillas; W S Velasquez; Peter McLaughlin; F B Hagemeister; F Swan; Maria A Rodriguez; William Plunkett; Michael J Keating
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(5):790-4.
1992: J A Spinolo; Fernando Cabanillas; D O Dixon; S M Khorana; Peter McLaughlin; W S Velasquez; F B Hagemeister; J R Redman; F Swan
Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(3):227-32.
1992: Fernando Cabanillas; W S Velasquez; F B Hagemeister; Peter McLaughlin; J R Redman
Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma.
Blood 1992;79(4):1024-8.
1992: Shiao Y Woo; Lillian M Fuller; J H Cundiff; Melissa L Bondy; F B Hagemeister; Peter McLaughlin; W S Velasquez; F Swan; Maria A Rodriguez; Fernando Cabanillas
Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease.
International journal of radiation oncology, biology, physics 1992;23(2):407-12.
1991: P Litam; F Swan; Fernando Cabanillas; Susan L Tucker; Peter McLaughlin; F B Hagemeister; Maria A Rodriguez; W S Velasquez
Prognostic value of serum beta-2 microglobulin in low-grade lymphoma.
Annals of internal medicine 1991;114(10):855-60.
1991: Jorge Romaguera; Peter McLaughlin; LB North; D Dixon; K B Silvermintz; L A Garnsey; W S Velasquez; F B Hagemeister; Fernando Cabanillas
Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(5):762-9.
1991: W S Velasquez; Lillian M Fuller; Sundar Jagannath; Susan L Tucker; LB North; F B Hagemeister; Peter McLaughlin; F Swan; J R Redman; Maria A Rodriguez
Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy.
Blood 1991;77(5):942-7.
1991: LE Robertson; J R Redman; J J Butler; B M Osborne; W S Velasquez; Peter McLaughlin; F Swan; Maria A Rodriguez; F B Hagemeister; Lillian M Fuller
Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(2):236-42.
1991: Peter McLaughlin; L Fuller; J Redman; F Hagemeister; E Durr; P Allen; L Holmes; W Velasquez; F Swan; Fernando Cabanillas
Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():137-40.
1991: F B Hagemeister; Lillian M Fuller; W S Velasquez; Peter McLaughlin; J R Redman; F Swan; Maria A Rodriguez; LB North; D Dixon; K Silvermintz
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(1):25-31.
1990: F B Hagemeister; Fernando Cabanillas; W S Velásquez; Marvin L Meistrich; Jan C Liang; Peter McLaughlin; J R Redman; Jorge Romaguera; M A Rodríguez; F Swan
NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
Seminars in oncology 1990;17(6 Suppl 10):34-8; discussion 38-40.
1990: J E Romagurea; W S Velasquez; K B Silvermintz; L B Fuller; F B Hagemeister; Peter McLaughlin; Fernando Cabanillas
Surgical debulking is associated with improved survival in stage I-II diffuse large cell lymphoma.
Cancer 1990;66(2):267-72.
1990: T M Lopez; F B Hagemeister; Peter McLaughlin; W S Velasquez; F Swan; J R Redman; Maria A Rodriguez; Susan L Tucker; K Silvermintz; J Johnson
Small noncleaved cell lymphoma in adults: superior results for stages I-III disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(4):615-22.
1990: B M Osborne; M O Uthman; J J Butler; Peter McLaughlin
Differentiation of T-cell lymphoma from Hodgkin's disease. Mitotic rate and S-phase analysis.
American journal of clinical pathology 1990;93(2):227-32.
1989: F Swan; W S Velasquez; S Tucker; J R Redman; Maria A Rodriguez; Peter McLaughlin; F B Hagemeister; Fernando Cabanillas
A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1518-27.
1989: Fernando Cabanillas; Sen Pathak; G Grant; F B Hagemeister; Peter McLaughlin; F Swan; Maria A Rodriguez; J Trujillo; A Cork; J J Butler
Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma.
The American journal of medicine 1989;87(2):167-72.
1989: W S Velasquez; Sundar Jagannath; Susan L Tucker; Lillian M Fuller; LB North; J R Redman; F Swan; F B Hagemeister; Peter McLaughlin; Fernando Cabanillas
Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data.
Blood 1989;74(2):551-7.
1989: K I Wishnow; J Y Ro; Peter McLaughlin
Paraepididymal relapse of follicular small cleaved cell lymphoma.
Urologia internationalis 1989;44(1):50-2.
1989: J A Spinolo; Sundar Jagannath; K A Dicke; K E Smith; Fernando Cabanillas; F B Hagemeister; L J Horwitz; Peter McLaughlin; F Swan; G Spitzer
High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide, and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin's disease: the M. D. Anderson experience.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():233-8.
1988: Peter McLaughlin; B M Osborne; D Johnston; P Jennings; J J Butler; Fernando Cabanillas; Bart Barlogie
Nucleic acid flow cytometry in large cell lymphoma.
Cancer research 1988;48(22):6614-9.
1988: Peter McLaughlin; W S Velasquez; J R Redman; W K Alfred Yung; F B Hagemeister; Maria A Rodriguez; Fernando Cabanillas
Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma.
Journal of the National Cancer Institute 1988;80(17):1408-12.
1988: Fernando Cabanillas; Sen Pathak; J Trujillo; J Manning; R Katz; Peter McLaughlin; W S Velasquez; F B Hagemeister; AM Goodacre; A Cork
Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma.
Cancer research 1988;48(19):5557-64.
1988: Fernando Cabanillas; Sen Pathak; J Trujillo; G Grant; A Cork; F B Hagemeister; W S Velasquez; Peter McLaughlin; J Redman; R Katz
Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte.
Blood 1988;71(6):1615-7.
1988: Fernando Cabanillas; W S Velasquez; Peter McLaughlin; Sundar Jagannath; F B Hagemeister; J R Redman; F Swan; Maria A Rodriguez
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
Seminars in hematology 1988;25(2 Suppl 2):47-50.
1988: W S Velasquez; Fernando Cabanillas; P Salvador; Peter McLaughlin; M Fridrik; S Tucker; Sundar Jagannath; F B Hagemeister; J R Redman; F Swan
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).
Blood 1988;71(1):117-22.
1987: D O Dixon; Peter McLaughlin; F B Hagemeister; Emil J Freireich; L M Fuller; Fernando Cabanillas; Edmund Gehan
Reporting outcomes in Hodgkin's disease and lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(10):1670-2.
1987: M S Lee; M B Blick; S Pathak; J M Trujillo; J J Butler; Ruth Katz; Peter McLaughlin; F B Hagemeister; W S Velasquez; AM Goodacre
The gene located at chromosome 18 band q21 is rearranged in uncultured diffuse lymphomas as well as follicular lymphomas.
Blood 1987;70(1):90-5.
1987: Peter McLaughlin; L M Fuller; W S Velasquez; J J Butler; F B Hagemeister; J A Sullivan-Halley; D O Dixon
Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(6):867-74.
1987: F B Hagemeister; N Tannir; Peter McLaughlin; P Salvador; S Riggs; W S Velasquez; Fernando Cabanillas
MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(4):556-61.
1987: Fernando Cabanillas; F B Hagemeister; Peter McLaughlin; W S Velasquez; S Riggs; L Fuller; T Smith
Results of MIME salvage regimen for recurrent or refractory lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(3):407-12.
1986: Peter McLaughlin; L M Fuller; W S Velasquez; J A Sullivan-Halley; J J Butler; F Cabanillas
Stage I-II follicular lymphoma. Treatment results for 76 patients.
Cancer 1986;58(8):1596-602.
1984: H M Kantarjian; Peter McLaughlin; L M Fuller; D O Dixon; B M Osborne; Fernando Cabanillas
Follicular large cell lymphoma: analysis and prognostic factors in 62 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(7):811-9.
1984: M F da Cunha; M L Meistrich; Lillian M Fuller; J H Cundiff; F B Hagemeister; W S Velasquez; Peter McLaughlin; S A Riggs; Fernando Cabanillas; P G Salvador
Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(6):571-7.
1983: T Flippin; Peter McLaughlin; F G Conrad; Lillian M Fuller; W S Velasquez; J J Butler; C C Shullenberger
Stage III nodular lymphomas. Preliminary results of a combined chemotherapy/radiotherapy program.
Cancer 1983;51(6):987-93.
1981: F B Hagemeister; Lillian M Fuller; J A Sullivan; LB North; W Velasquez; F G Conrad; Peter McLaughlin; J J Butler; C C Shullenberger
Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
Radiology 1981;141(3):783-9.